|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized phase Ⅱ study of gemcitabine plus cisplatin,with or without cetuximab, as first-line therapy for patients with advanced or metastatic non-small cell lung cancer 显示文摘 | Butts CA Bodkin D MiddIeman EL | 2007 | J Clin Oncol2007，25，36： | 1 |
| 2 | A comparison of the antitumor efficacy of ZD6474 and gefitinib (lressa) in patients with NSCLC : results of a randomized, double blind, phase Ⅱ study显示文摘 | Natale R Bodkin D Govindan R | 2005 | Clin Lung Cancer2005，49，2： | 1 |
| 3 | Vandetan-ib versus gefitinib in patients with advanced non-small-ce-ll lung cancer:results from a two-part,double-blind,ran-domized phaseⅡstudy显示文摘 | Natale RB Bodkin D Govindan R | 2009 | J Clin Oncol2009，27，15： | 1 |
| 4 | A comparison of the antitu mour eficacy of ZD6474 and gefitinib (Iressa) in patients with NSCLC: Result s of a randomized, double-blind Phas Ⅱ study 显示文摘 | Natale R Bodkin D Govindan R | 2005 | Lung Cancer2005，49，2： | 1 |
| 5 | An exploratory investigation of problematic online auction behaviors:experiences of ebay users 显示文摘 | Peters C Bodkin C D | 2007 | Journal of Retailing and Consumer Services2007，14，： | 1 |
| 6 | Vandetanib versus gefi- tinib in patients with advanced non-small-ceU lung cancer: results from a two-part, double-blind, randomized phase ii study 显示文摘 | Natale RIB Bodkin D Govindan R | 2009 | Jour- nal of Clinical Oncology2009，27，15： | 1 |
| 7 | Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-Part, double-blind, randomized phase Ⅱ study显示文摘 | Natale R B Bodkin D Govindan R | 2009 | J Clin Oncol2009，27，15： | 1 |
| 8 | Vandetanib versus gefitinib in patients with advanced non - small - cell lung cancer: results from a two - part, double - bhnd, randomized phase ii study 显示文摘 | Natale RB Bodkin D Govindan R | 2009 | J Clin On- col2009，27，15： | 1 |
| 9 | Randomized phase II study of gemcitabine plus cisplatin or carboplatin (corrected), with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer显示文摘 | Butts C A Bodkin D Middleman E L | 2007 | J Clin Oncol2007，25，36： | 1 |
| 10 | Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer:results from a two-part,double-blind,randomized phase Ⅱ study显示文摘 | Natale RB Bodkin D Govindan R | | 0，，15： | 1 |
| 11 | Randomized phase ]l study of gemcitabine plus cisplatin or carboplatin, with or without cetuximab, as first-line therapy for patients with ad- vanced or metastatic non-small cell lung cancer 显示文摘 | Butts CA Bodkin D Middleman EL | 2007 | J Clin Oncol2007，25，36： | 1 |
| 12 | ZD6474versus gefitinib in patients with advanced NSCLC:Final results from a two-part,double-blind,randomized phase Ⅱ] trial显示文摘 | NATALE R B BODKIN D GOVINDAN R | 2006 | J Clin Oncol2006，，36： | 1 |
| 13 | Transdermal sclegiline in major depression:a double-blind,placebo-controlled,parallel-group study in outpatients显示文摘 | BODKIN J A AMSTERDAM J D | 2002 | Am J Psychiatry2002，159，11： | 1 |
| 14 | ZD6474versus gefitinib in patients with advanced NSCLC: Final results from a two-part, double-blind, randomized phase Ⅱ trial显示文摘 | Natale R B Bodkin D Govindan R | 2006 | J Clin Oncol2006，，： | 1 |
| 15 | Randomized phase II study of gemcitabine plus cisplatin or carboplatin, with or without cetuximab, as first- line therapy for patients with advanced or metastatic non small- cell lung cancer 显示文摘 | Butts CA Bodkin D Middleman EL et al | 2007 | J Clin Oncol2007，25，36： | 1 |
| 16 | Randomized phase Ⅱ study of gemcitabine plus cisplatin or carboplatin , with or without cetuximab, as first-line therapy for patients with advanced or metastatic nonsmall-cell lung cancer 显示文摘 | Butts CA Bodkin D Middleman EL | 2007 | J Clin Oncol2007，25，36： | 1 |
| 17 | A comparison of the antitumour efficacy of ZD6474 and gefitinib (Iressa) in patients with NSCLC:Results of a randomized,double-blind PhaseⅡstudy显示文摘 | Natale R Bodkin D Govindan R | 2005 | Lung Cancer2005，49，2： | 1 |
| 18 | Cities as Hnvironments显示文摘 | Bodkin D B Beverage C E | | Urban Ecosystems0，1，1： | 1 |
| 19 | Randomizedphase II study of gemcitabine plus cisplatin or carboplatin,withor without cetuximab,as first-line therapy for patients with ad-vanced or metastatic non small-cell lung cancer 显示文摘 | Butts C A Bodkin D Middleman EL | 2007 | J Clin On-col2007，25，36： | 1 |
| 20 | An exploratory investigation of problematic online auction behaviors: Experiences of eBay users显示文摘 | Peters C Bodkin C D | 2007 | Journal of Retailing and Consumer Services2007，14，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员